Raltegravir from MedChemExpress

Product Specs
ItemRaltegravir
CompanyMedChemExpress
Price $85.00Supplier Page View Company Product Page
Catalog NumberHY-10353
Quantity10 mM * 1 mL
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.93%
TypeChemical
Molecular Weight444.42
Molecule NameRaltegravir
FormulaC20H21FN6O5
Research AreaInfection; Cancer

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) BACH2 promotes seeding and establishment of long-lived HIV-1 reservoir in memory CD4+ T cellsCell Reports MedicineSeptember 16, 2025Hongbo Gao, Yuhao Li, Ritudwhaj Tiwari, Marilia Pinzone, Xiwen Qin, Kolin M. Clark, Sara K. Nicholson, Tony Yao, Kelly Rome, Michael Scaglione, et al.(PHA-L),Sigma,11249738001 Enfuvirtide (T-20),MedChemExpress,HY-P0052 Raltegravir (RAL),MedChemExpress,HY-10353 Recombinant Cas9 protein,IDT,1081059 Random Primers,Invitrogen,48190–011 ProtoScript II Reverse Transcriptase,NEB,M0368 "RNase Inhibitor, Murine

(2) The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infectionPLOS PathogensJanuary 17, 2025Nicholas Rohlfes, Rajalingam Radhakrishnan, Parmit K. Singh, Gregory J. Bedwell, Alan N. Engelman, Adarsh Dharan, Edward M. Campbellexpression. CsA was purchased from Sigma-Aldrich. RAL was purchased from MedChemExpress (Catalogue no. HY-10353). Hoechst was purchased from ImmunoChemistry Technologies (Catalogue no. 639). Western blot Cell lysates

(3) Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing StrategyMoleculesMarch 24, 2024Silvia Cesarini, Ilaria Vicenti, Federica Poggialini, Silvia Filippi, Eleonora Mancin, Lia Fiaschi, Elisa De Marchi, Federica Giammarino, Chiara Vagaggini, Bruno Mattia Bizzarri, et al.Euroclone S.p.A. (Milan, Italy). SOF (MCE® cat. HY-15005), REM (MCE® cat. HY-104077) and RAL (MCE® cat. HY-10353), used as reference compounds, were purchased from MedChem Express (https://www.medchemexpress.com,

(4) Spastin is required for human immunodeficiency virus-1 efficient replication through cooperation with the endosomal sorting complex required for transport (ESCRT) proteinVirologica SinicaJune 1, 2023Shen W, Liu C, Hu Y, Ding Q, Feng J, Liu Z, Kong X.5′-TGCATGGGTAAAAGTAGTAGAAGAGA-3′; reverse, 5′-TGATAATGCTGAAA ACATGGGTA-3′). HIV-1 integrase inhibitor raltegravir (HY-10353, MedChemExpress, New Jersey, USA) was used as a positive control. 2.7 Release efficiency Cells were

(5) Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 ActivityMoleculesDecember 12, 2022Silvia Cesarini, Ilaria Vicenti, Federica Poggialini, Massimiliano Secchi, Federica Giammarino, Ilenia Varasi, Camilla Lodola, Maurizio Zazzi, Elena Dreassi, Giovanni Maga, et al.half-maximal cytotoxic concentration (CC50). Remdesivir (MCE® cat. HY-104077) and Raltegravir (MCE® cat. HY-10353), used as reference compounds for SARS-CoV-2 and HIV-1 antiviral tests, respectively, were purchased

(6) Effective Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus in an in vitro ModelFrontiers in MedicineMarch 31, 2022Mi-Seon Bang, Choon-Mee Kim, Dong-Min Kim, Na Ra Yun(HY-13997), oseltamivir (HY-13318), penciclovir (HY-17424), perindopril salt (HY-B0130A), raltegravir (HY-10353), remdesivir (GS-5734, HY-104077), rilpivirine (HY-10574), ritonavir (HY-90001), simeprevir (HY-10241),

(7) Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In VitroJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune PharmacologyDecember 1, 2017Xu P, Wang Y, Qin Z, Qiu L, Zhang M, Huang Y, Zheng JC.

(8) Divalent metals and pH alter raltegravir disposition in vitroAntimicrobial agents and chemotherapyJune 1, 2012Moss DM, Siccardi M, Murphy M, Piperakis MM, Khoo SH, Back DJ, Owen A.

(9) Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572)Molecular pharmacologyOctober 1, 2011Hare S, Smith SJ, Métifiot M, Jaxa-Chamiec A, Pommier Y, Hughes SH, Cherepanov P.

(10) Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistanceProceedings of the National Academy of Sciences of the United States of AmericaNovember 16, 2010Hare S, Vos AM, Clayton RF, Thuring JW, Cummings MD, Cherepanov P.

(11) Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapyRetrovirologyMarch 16, 2010Lewis MG, Norelli S, Collins M, Barreca ML, Iraci N, Chirullo B, Yalley-Ogunro J, Greenhouse J, Titti F, Garaci E, et al.

(12) Raltegravir: the first HIV type 1 integrase inhibitorClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaApril 1, 2009Hicks C, Gulick RM.

Be the First to Write a Review!

Raltegravir from MedChemExpress

Description

MedChemExpress

Citations (12)

Reviews

Raltegravir from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map